SEC Form 4 · accession 0001055726-18-000022
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jong Joseph Kim
Officer — Chief Executive Officer · Director
Period of report
Apr 12, 2018
Accepted (ET)
Apr 13, 2018 · 6:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 12, 2018 | M | 103,750 | $2.40 | A | 2,395,557 | D | |
| Common Stock | Apr 12, 2018 | S | 103,750 | $5.1387 | D | 2,291,807 | D | |
| Common Stock | Apr 13, 2018 | M | 107,500 | $2.16 | A | 2,399,307 | D | |
| Common Stock | Apr 13, 2018 | S | 107,500 | $5.055 | D | 2,291,807 | D | |
| Common Stock | holding | — | — | — | 1,750,000 | I | By Family Limited Partnership | |
| Common Stock | holding | — | — | — | 33,563 | I | By Daughter: EK | |
| Common Stock | holding | — | — | — | 33,775 | I | By Son: JK1 | |
| Common Stock | holding | — | — | — | 5,975 | I | By Spouse | |
| Common Stock | holding | — | — | — | 33,533 | I | By Son: JK2 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Option | $2.40 | Apr 12, 2018 | M | 103,750 | D | Feb 23, 2012 | Feb 23, 2022 | Common Stock | 103,750 | 0 | D |
| Common Stock Option | $2.16 | Apr 13, 2018 | M | 107,500 | D | Mar 14, 2013 | Mar 14, 2023 | Common Stock | 107,500 | 0 | D |